647 filings
Page 3 of 33
8-K
4kyfgwyd1
17 Aug 20
Other Events
4:41pm
NT 10-Q
fw5 1qp4wl
10 Aug 20
Notice of late quarterly filing
9:35pm
8-K
11v tvu2ozqdn2
6 Aug 20
Amag Pharmaceuticals Announces Second Quarter 2020 Financial Results
7:06am
8-K
1mjczpx3dkt474ua13
27 Jul 20
Amag Pharmaceuticals Completes Divestment of Women’s Health Assets
7:38am
8-K
82utcagyaabc4
23 Jul 20
Amag Pharmaceuticals and Norgine B.V. Enter into Exclusive Licensing Agreement to Commercialize Ciraparantag In Europe, Australia and New Zealand
9:24am
8-K
55ke oi7dmazdi
11 Jun 20
Amag Pharmaceuticals Announces Leadership Changes
7:13am
8-K
20i32
4 Jun 20
Submission of Matters to a Vote of Security Holders
4:41pm
8-K
bf5duve9 i5
21 May 20
Amag Pharmaceuticals Completes Sale of Its Rights to Intrarosa® to Millicent Pharma for Up to $125 Million
9:34pm
8-K
5iso 9ohk
11 May 20
Amag Pharmaceuticals Announces First Quarter 2020 Financial Results
7:18am
CT ORDER
vcrzg8 rk
6 May 20
Confidential treatment order
2:51pm
CT ORDER
0yksh4
6 May 20
Confidential treatment order
2:51pm
CT ORDER
ms9px5kldqx6hg89
6 May 20
Confidential treatment order
2:50pm
CT ORDER
nyie9 66mjj
6 May 20
Confidential treatment order
2:49pm
8-K
z22oxy7i3ng30hgfdoak
28 Apr 20
AMAG Pharmaceuticals Appoints Scott Myers as President and Chief Executive Officer
7:34am
8-K
9d55q
16 Apr 20
Amag Pharmaceuticals Provides COVID-19 Company Update
7:45am